Literature DB >> 25409386

Carcinoma of unknown primary site.

Gauri R Varadhachary, Martin N Raber.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25409386     DOI： 10.1056/NEJMc1411384

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.

Authors:  Peng Zhao; Ling Peng; Wei Wu; Yi Zheng; Weiqin Jiang; Hangyu Zhang; Zhou Tong; Lulu Liu; Ruobing Ma; Liping Wang; Ming Yao; Kai Wang; Weijia Fang; Liming Wu
Journal:  Oncologist       Date:  2019-01-24

2.  Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

Authors:  Shumei Kato; Nithya Krishnamurthy; Kimberly C Banks; Pradip De; Kirstin Williams; Casey Williams; Brian Leyland-Jones; Scott M Lippman; Richard B Lanman; Razelle Kurzrock
Journal:  Cancer Res       Date:  2017-06-22       Impact factor: 12.701

Review 3.  Cancer of Unknown Primary in the Molecular Era.

Authors:  Shumei Kato; Ahmed Alsafar; Vighnesh Walavalkar; John Hainsworth; Razelle Kurzrock
Journal:  Trends Cancer       Date:  2021-01-28

4.  Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.

Authors:  Kanwal Raghav; Hemendra Mhadgut; Jennifer L McQuade; Xiudong Lei; Alicia Ross; Aurelio Matamoros; Huamin Wang; Michael J Overman; Gauri R Varadhachary
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  Molecular driver alterations and their clinical relevance in cancer of unknown primary site.

Authors:  Harald Löffler; Nicole Pfarr; Mark Kriegsmann; Volker Endris; Thomas Hielscher; Philipp Lohneis; Gunnar Folprecht; Albrecht Stenzinger; Manfred Dietel; Wilko Weichert; Alwin Krämer
Journal:  Oncotarget       Date:  2016-07-12

6.  Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.

Authors:  Makoto Kodaira; Kan Yonemori; Tatsunori Shimoi; Akihiko Yoshida; Masayuki Yoshida; Atsuko Kitano; Akihiko Shimomura; Mayu Yunokawa; Chikako Shimizu; Yuichi Takiguchi; Yasuhiro Fujiwara; Kenji Tamura
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

Review 7.  Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?

Authors:  Tilmann Bochtler; Alwin Krämer
Journal:  Front Oncol       Date:  2019-05-17       Impact factor: 6.244

8.  Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait.

Authors:  Ryan W Huey; Brandon G Smaglo; Jeannelyn S Estrella; Aurelio Matamoros; Michael J Overman; Gauri R Varadhachary; Kanwal P S Raghav
Journal:  Oncologist       Date:  2021-02-15

9.  Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

Authors:  Elena F Brachtel; Theresa N Operaña; Peggy S Sullivan; Sarah E Kerr; Karen A Cherkis; Brock E Schroeder; Sarah M Dry; Catherine A Schnabel
Journal:  Oncotarget       Date:  2016-05-10

10.  Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy.

Authors:  Kentaro Miyake; Tasuku Kiyuna; Masuyo Miyake; Kei Kawaguchi; Sang Nam Yoon; Zhiying Zhang; Kentaro Igarashi; Sahar Razmjooei; Sintawat Wangsiricharoen; Takashi Murakami; Yunfeng Li; Scott D Nelson; Tara A Russell; Arun S Singh; Yukihiko Hiroshima; Masashi Momiyama; Ryusei Matsuyama; Takashi Chishima; Shree Ram Singh; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Signal Transduct Target Ther       Date:  2018-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.